L I Pavlova - JoVE Visualize

Showing results (31-40 of 46) with videos related to

Pageof 5

Sort By:

Voprosy Virusologii|March 1, 2000

[Characteristics of "Avaxim" hepatitis A vaccine produced by the firm "Pasteur Merrier" (results of field clinical trials)]M A Gorbunov, A V Noskova, G A El'shina, et al.

Bulletin of Experimental Biology and Medicine|September 11, 2001

Phospholipid composition of high-density lipoproteins reflects lipolysis of triglyceride-rich lipoproteins during hyperlipidemiaN V Perova, I N Ozerova, I V Paramonova, et al.

Cor Et Vasa|January 1, 1989

Mortality and morbidity indicators of acute myocardial infarction in participants and non-participants in population studies conducted in Moscow and KaunasA A Tamosjunas, A V Baubiniene, L V Chazova, et al.

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|February 14, 1998

[The efficacy of recombinant vaccines against hepatitis B and the results of their use in a schedule for pediatric prophylactic inoculations]M A Gorbunov, L I Pavlova, I A Titov, et al.

Terapevticheskii Arkhiv|January 1, 1996

[The effect of micronized phenofibrate on the lipoproteins of the blood plasma at different initial lipid levels]N V Perova, I N Ozerova, A M Kalinina, et al.

Kardiologiia|January 1, 1993

[Long-term results of the program for preventing ischemic heart disease in Moscow (10-year follow-up study)]A M Kalinina, L V Chazova, L I Pavlova, et al.

Voprosy Virusologii|September 1, 1993

[A comparative evaluation of the immunogenicity and reactogenicity of recombinant vaccines against hepatitis B]M A Gorbunov, L I Pavlova, A V Noslova, et al.

Voprosy Virusologii|September 1, 1995

[Evaluation of reactivity and immunogenicity of a cultured concentrated inactivated vaccine against hepatitis A "Hep-A-In-Vak"]M A Gorbunov, L I Pavlova, L G Karpovich, et al.

Voprosy Virusologii|November 1, 1995

[Comparative study of the immunogenicity of the inactivated hepatitis A vaccine Hep-A-in-vac from experimental and clinical data]L G Karpovich, T V Kalashnikova, M A Gorbunov, et al.

Voprosy Virusologii|February 24, 2001

[Comparative study of the reactivity, safety and immunogenicity of "Havrix" inactivated hepatitis A vaccine]A V Noskova, M A Gorbunov, L I Pavlova, et al.

Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:

Pageof 5

Voprosy Virusologii|March 1, 2000

[Characteristics of "Avaxim" hepatitis A vaccine produced by the firm "Pasteur Merrier" (results of field clinical trials)]M A Gorbunov, A V Noskova, G A El'shina, et al.

Bulletin of Experimental Biology and Medicine|September 11, 2001

Phospholipid composition of high-density lipoproteins reflects lipolysis of triglyceride-rich lipoproteins during hyperlipidemiaN V Perova, I N Ozerova, I V Paramonova, et al.

Cor Et Vasa|January 1, 1989

Mortality and morbidity indicators of acute myocardial infarction in participants and non-participants in population studies conducted in Moscow and KaunasA A Tamosjunas, A V Baubiniene, L V Chazova, et al.

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii|February 14, 1998

[The efficacy of recombinant vaccines against hepatitis B and the results of their use in a schedule for pediatric prophylactic inoculations]M A Gorbunov, L I Pavlova, I A Titov, et al.

Terapevticheskii Arkhiv|January 1, 1996

[The effect of micronized phenofibrate on the lipoproteins of the blood plasma at different initial lipid levels]N V Perova, I N Ozerova, A M Kalinina, et al.

Kardiologiia|January 1, 1993

[Long-term results of the program for preventing ischemic heart disease in Moscow (10-year follow-up study)]A M Kalinina, L V Chazova, L I Pavlova, et al.

Voprosy Virusologii|September 1, 1993

[A comparative evaluation of the immunogenicity and reactogenicity of recombinant vaccines against hepatitis B]M A Gorbunov, L I Pavlova, A V Noslova, et al.

Voprosy Virusologii|September 1, 1995

[Evaluation of reactivity and immunogenicity of a cultured concentrated inactivated vaccine against hepatitis A "Hep-A-In-Vak"]M A Gorbunov, L I Pavlova, L G Karpovich, et al.

Voprosy Virusologii|November 1, 1995

[Comparative study of the immunogenicity of the inactivated hepatitis A vaccine Hep-A-in-vac from experimental and clinical data]L G Karpovich, T V Kalashnikova, M A Gorbunov, et al.

Voprosy Virusologii|February 24, 2001

[Comparative study of the reactivity, safety and immunogenicity of "Havrix" inactivated hepatitis A vaccine]A V Noskova, M A Gorbunov, L I Pavlova, et al.

Pageof 5